A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification

Nat Chem Biol. 2014 Aug;10(8):629-31. doi: 10.1038/nchembio.1581. Epub 2014 Jul 6.

Abstract

We report that 4-(3-(benzyloxy)phenyl)-2-ethylsulfinyl-6-(trifluoromethyl)pyrimidine (BETP), which behaves as a positive allosteric modulator at the glucagon-like peptide-1 receptor (GLP-1R), covalently modifies cysteines 347 and 438 in GLP-1R. C347, located in intracellular loop 3 of GLP-1R, is critical to the activity of BETP and a structurally distinct GLP-1R ago-allosteric modulator, N-(tert-butyl)-6,7-dichloro-3-(methylsulfonyl)quinoxalin-2-amine. We further show that substitution of cysteine for phenylalanine 345 in the glucagon receptor is sufficient to confer sensitivity to BETP.

MeSH terms

  • Animals
  • CHO Cells
  • Cricetulus
  • Cysteine / chemistry
  • Glucagon-Like Peptide 1 / agonists
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Ligands
  • Pyrimidines / chemistry*
  • Pyrimidines / metabolism
  • Receptors, Glucagon / chemistry
  • Receptors, Glucagon / metabolism*

Substances

  • 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine
  • GLP1R protein, human
  • Glucagon-Like Peptide-1 Receptor
  • Ligands
  • Pyrimidines
  • Receptors, Glucagon
  • Glucagon-Like Peptide 1
  • Cysteine

Associated data

  • PubChem-Substance/183814150
  • PubChem-Substance/183814151
  • PubChem-Substance/183814152
  • PubChem-Substance/183814153
  • PubChem-Substance/183814154